Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: Relationship to lipid peroxidation

International Journal of Cancer

Volumn 75, Issue 4, 1998, Pages 578-583

  Germain, Emmanuelle ^a   Chajès, Véronique ^a   Cognault, Sophie ^a   Lhcillery, Claude ^a   Bougnoux, Philippe ^a,b  

^a CEMAGREF   (France)

^b CHU BRETONNEAU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; ASCORBIC ACID; DOCOSAHEXAENOIC ACID; DOXORUBICIN; GAMMA LINOLENIC ACID; HYDROPEROXIDE; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; LIPID PEROXIDE; MENADIONE; MITOXANTRONE; OLEIC ACID; OXIDIZING AGENT; POLYUNSATURATED FATTY ACID;

ARTICLE; BREAST TUMOR; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; TUMOR CELL LINE;

BREAST NEOPLASMS; DOCOSAHEXAENOIC ACIDS; DOXORUBICIN; DRUG SYNERGISM; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; LIPID PEROXIDES; OXIDANTS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0032498548     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980209)75:4<578::AID-IJC14>3.0.CO;2-5     Document Type: Article

References (26)

1. BÉGIN, M., ELLS, G. and HORROBIN, D., Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to Jipid peroxidation. J. nat. Cancer Inst., 80, 188-194 (1988).
2. BENCHEKROUN, N. and ROBERT, J., Measurement of doxorubicin-induced lipid peroxidation under the conditions that determine cytotoxicity in cultured tumor cells. Anal. Biochem., 201, 326-330 (1992).
3. BENCHEKROUN, N.M., POURQUIER, P., SCHOTT, B. and ROBERT, J., Doxorubicin-induced lipid peroxidation and glutathione peroxidase activity in tumor cell lines selected for resistance to doxorubicin. Europ. J. Biochem., 211, 141-146 (1993).
4. BLIGH, E.G. and DYER, W.J., Rapid method of total lipid extraction and purification. Canad. J. Biochem. Physiol., 37, 911-917 (1959).
5. BOUGNOUX, P., CHAJÈS, V. HUBERT, B., GERMAIN, E., LHUILLERY, C., SAEZ, S. and CALAIS, G., N-3 polyunsaturated fatty acids and chemosensitivity of breast carcinoma. Proc. Amer. Ass. Cancer Res., 36, 237 (abstract 1947) (1995).
6. BURNS, C.P. and NORTH, J.A., Adriamycin transport and sensitivity in fatty acid-modified leukemia cells. Biochim. biophys. Acta., 888, 10-17 (1986).
7. CHAJÈS, V., LANSON, M., FÉTISSOF, F., LHUILLERY, C. and BOUGNOUX, P., Membrane fatty acids of breast carcinoma: contribution of host fatty acids and tumor properties. Int. J. Cancer, 63, 169-175 (1995).
8. CHAJÈS, V., SATTLER, W., STRANZL, A. and KOSTNER, G., Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: a relationship to peroxides and vitamin E. Breast Cancer Res. Treat., 34, 199-212 (1996).
9. DOROSHOW, J., Comparative cardiac oxygen radical metabolism by anthracycline antibiotics, mitoxantrone, bisantrene, 4′-(9-acridylamino-metasulfon- n-anisidide, and neocarzino-statin. Biochem. Pharmacol., 32, 2935-2939 (1983).
10. EL SAADANI, M., ESTERBAUER, H., EL-SAYED, M., GOHER, M., NASSAR, A.Y. and JURGENS, G., A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res., 30, 627-630 (1989).
11. ESTERBAUER, H., SHAÜR, R. and ZOLLNER, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad. Biol. Med., 11, 81-128 (1991).
12. FABER, M., COUDRAY, C., HIDA, H., MOUSSEAU, M. and FAVIER, A., Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy including adriamycin. Biol. Trace Element Res., 47, 117-123 (1995).
13. FISHER, G. and PATTERSON, L., Lack of involvement of reactive oxygen in the cytotoxicity of mitoxantrone, C1941 and ametantrone in MCF-7 cells: comparison with doxorubicin. Cancer Chemother. Pharmacol., 30, 451-458 (1992).
14. GONZALEZ, M.J., SCHEMMEL., R.A., GRAY, J.I., DUGAN, L. and WELSCH, C.W., Dietary fish oil inhibits human breast carcinoma growth: a function of increased lipid peroxidation. Lipids, 28, 827-833 (1993).
15. + antiporter activity in relation to membrane fatty acid composition and cell proliferation. Amer. J. Physiol., 266, C110-C120 (1994).
16. HAUPTLORENZ, S., ESTERBAUER, H., MOLL, W., PUMPEL, R., SCHAUENSTEIN, E. and PUSCHKNDORF, B., Effects of the lipid peroxidation product 4-hydroxynonenal and related aldehydes on proliferation and viability of cultured Ehrlich ascites tumor cells. Biochem. Pharmacol., 34, 3803-3809 (1985).
17. HE, N.G., SINGHAL, S.S., SKRIVASTAVA, S.K., ZIMNIAK, P., AWASTHI, Y.C. and AWASTHI, S., Transfection of a 4-hyroxynonenal metabolizing glutathione 5-transferase isozyme, mouse GSTA4-4. confers doxorubicin resistance to Chinese hamster ovary cells. Arch. Biochem. Biophys., 333, 214-220 (1996).
18. KHARASCH, E.D. and NOVAK, R.F., Mitoxantrone and ametantrone inhibit hydroperoxide-dependent initiation and propagation reactions in fatty acid peroxidation. J. biol. Chem., 260, 10645-10652 (1985).
19. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. and RANDALL, R.J., Protein measurement with Folin phenol reagent. J. biol. Chem., 193, 265-275 (1951).
20. NOTO, V. TAPER, H.S., YL-HUA, J., JANSSENS, J., BONTE, J. and DE LOECKER, W., Effects sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. Synergism of combined vitamin C and K3 action. Cancer, 63, 901-906 (1989).
21. PETERSEN, E.S., KELLEY, E.E., MODEST, E. and BURNS, C.P., Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM41.140. Cancer Res., 42, 6263-6269 (1992).
22. SANDSTROM, P.A., PARDI, D., TEBBLY, P.W., DUDEK, R., TERRIAN, D., FOLKS, T. and BUTTKE, T., Lipid hydroperoxide-induced apoptosis: lack of inhibition by Bcl-2 overexpression. FEBS Lett., 365, 66-70 (1995).
23. SHAO, Y., PAKDINI, L. and PARDINI, R.S., Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1. Lipids, 30, 1035-1045 (1995).
24. TESSITORE, L., BONNELLI, G., MATERA, L., PILERI, A., BACCINO, P.M. and DIANZANI, M., Effect of two aliphatic aldehydes, methylglyoxal and 4-hydroxypentenal on the growth of Yoshida ascites hepatoma AH-130. Chem. biol. Interact., 70, 227-240 (1989).
25. VILE, G.F. and WINTERBOUN, C.C., Microsomal lipid peroxidation induced by adriamycin, epirubicin, daunorubicin and mitoxantrone: a comparative study. Cancer Chemother. Pharmacol., 24, 105-108 (1989).
26. ZIJLSTRA, J.G., DE VRIES, E.G., MUSKIET, F.A., MARTINI, I.A., TIMMER-BOSSCHA, H. and MULDER, N.H., Influence of docosahexaenoic acid in vitro in intracellular adriamycin concentration in lymphocytes and human adriamycin-sensitive and -resistant small-cell lung cancer cell lines, and on cytotoxicity in the tumor cell lines. Int. J. Cancer. 40, 850-856 (1987).